United States - English - NLM (National Library of Medicine)

sandoz inc - betaxolol hydrochloride (unii: 6x97d2xt0o) (betaxolol - unii:o0zr1r6rz2) - betaxolol hydrochloride 5.6 mg in 1 ml - betaxolol hydrochloride ophthalmic solution has been shown to be effective in lowering intraocular pressure and is indicated in the treatment of ocular hypertension and chronic open-angle glaucoma. it may be used alone or in combination with other anti-glaucoma drugs. in clinical studies, betaxolol hydrochloride ophthalmic solution was safely used to lower intraocular pressure in 47 patients with both glaucoma and reactive airway disease who were followed for a mean period of 15 months. however, caution should be used in treating patients with severe reactive airway disease or a history of asthma. hypersensitivity to any component of this product. betaxolol hydrochloride ophthalmic solution is contraindicated in patients with sinus bradycardia, greater than a first degree atrioventricular block, cardiogenic shock, or patients with overt cardiac failure. safety and effectiveness in pediatric patients have not been established. no overall differences in safety or effectiveness have been observed between elderly

United States - English - NLM (National Library of Medicine)

kvk-tech, inc. - betaxolol hydrochloride (unii: 6x97d2xt0o) (betaxolol - unii:o0zr1r6rz2) - betaxolol hydrochloride 10 mg - betaxolol tablets, usp is indicated in the management of hypertension. it may be used alone or concomitantly with other antihypertensive agents, particularly thiazide-type diuretics. betaxolol tablets, usp is contraindicated in patients with known hypersensitivity to the drug. betaxolol tablets, usp is contraindicated in patients with sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure (see warnings ).

United States - English - NLM (National Library of Medicine)

akorn - betaxolol hydrochloride (unii: 6x97d2xt0o) (betaxolol - unii:o0zr1r6rz2) - betaxolol 5 mg in 1 ml - betaxolol ophthalmic solution has been shown to be effective in lowering intraocular pressure and is indicated in the treatment of ocular hypertension and chronic open-angle glaucoma. it may be used alone or in combination with other anti-glaucoma drugs. in clinical studies, betaxolol ophthalmic solution was safely used to lower intraocular pressure in 47 patients with both glaucoma and reactive airway disease who were followed for a mean period of 15 months. however, caution should be used in treating patients with severe reactive airway disease or a history of asthma. hypersensitivity to any component of this product. betaxolol is contraindicated in patients with sinus bradycardia, greater than a first degree atrioventricular block, cardiogenic shock, or patients with overt cardiac failure.

United States - English - NLM (National Library of Medicine)

puracap laboratories llc - betaxolol hydrochloride (unii: 6x97d2xt0o) (betaxolol - unii:o0zr1r6rz2) - betaxolol hydrochloride 10 mg - betaxolol is indicated in the management of hypertension. it may be used alone or concomitantly with other antihypertensive agents, particularly thiazide-type diuretics. betaxolol is contraindicated in patients with known hypersensitivity to the drug. betaxolol is contraindicated in patients with sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure. (see warnings).

United States - English - NLM (National Library of Medicine)

epic pharma llc - betaxolol hydrochloride (unii: 6x97d2xt0o) (betaxolol - unii:o0zr1r6rz2) - betaxolol hydrochloride 10 mg - betaxolol is indicated in the management of hypertension. it may be used alone or concomitantly with other antihypertensive agents, particularly thiazide-type diuretics. betaxolol is contraindicated in patients with known hypersensitivity to the drug. betaxolol is contraindicated in patients with sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure. (see warnings).

United States - English - NLM (National Library of Medicine)

physicians total care, inc. - betaxolol hydrochloride (unii: 6x97d2xt0o) (betaxolol - unii:o0zr1r6rz2) - betaxolol hydrochloride 10 mg - betaxolol is indicated in the management of hypertension. it may be used alone or concomitantly with other antihypertensive agents, particularly thiazide-type diuretics. betaxolol is contraindicated in patients with known hypersensitivity to the drug. betaxolol is contraindicated in patients with sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure. (see warnings).

United States - English - NLM (National Library of Medicine)

golden state medical supply, inc. - betaxolol hydrochloride (unii: 6x97d2xt0o) (betaxolol - unii:o0zr1r6rz2) - betaxolol hydrochloride 10 mg - betaxolol tablets, usp is indicated in the management of hypertension. it may be used alone or concomitantly with other antihypertensive agents, particularly thiazide-type diuretics. betaxolol tablets, usp is contraindicated in patients with known hypersensitivity to the drug. betaxolol tablets, usp is contraindicated in patients with sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure (see warnings).

United States - English - NLM (National Library of Medicine)

alcon laboratories, inc. - betaxolol hydrochloride (unii: 6x97d2xt0o) (betaxolol - unii:o0zr1r6rz2) - betaxolol hydrochloride 2.8 mg in 1 ml - betoptic s® (betaxolol hydrochloride ophthalmic suspension) 0.25% is indicated for the treatment of elevated intraocular pressure (iop) in patients with chronic open-angle glaucoma or ocular hypertension. betoptic s is contraindicated in patients with: - sinus bradycardia - greater than a first degree atrioventricular (av) block - cardiogenic shock - patients with overt cardiac failure - hypersensitivity to any component of this product risk summary there are no adequate and well-controlled studies of betoptic s administration in pregnant women to inform a drug-associated risk. there are limited data with the use of betaxolol eye drops in pregnant women. epidemiological studies have not revealed malformative effects but show a risk for intrauterine growth retardation when beta-blockers are administered by the oral route. in animal reproductive studies, no drug-induced maternal toxicity or teratogenicity was observed at clinically relevant doses (see data) . because animal reproductive studies are not always

United States - English - NLM (National Library of Medicine)

marlex pharmaceuticals inc - betaxolol hydrochloride (unii: 6x97d2xt0o) (betaxolol - unii:o0zr1r6rz2) - betaxolol hydrochloride 10 mg - betaxolol is indicated in the management of hypertension. it may be used alone or concomitantly with other antihypertensive agents, particularly thiazide-type diuretics. betaxolol is contraindicated in patients with known hypersensitivity to the drug. betaxolol is contraindicated in patients with sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure. (see warnings ).

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - betaxolol hydrochloride -